HRP931395B1 - Process for the preparation of crystalline form of sodium salt oxy derivatives of 7-amino-thiazolyl-acetamido-cephalosporin acid - Google Patents

Process for the preparation of crystalline form of sodium salt oxy derivatives of 7-amino-thiazolyl-acetamido-cephalosporin acid

Info

Publication number
HRP931395B1
HRP931395B1 HRP-1917/78A HRP931395A HRP931395B1 HR P931395 B1 HRP931395 B1 HR P931395B1 HR P931395 A HRP931395 A HR P931395A HR P931395 B1 HRP931395 B1 HR P931395B1
Authority
HR
Croatia
Prior art keywords
acetamido
thiazolyl
amino
preparation
sodium salt
Prior art date
Application number
HRP-1917/78A
Other languages
English (en)
Inventor
Gastons Amiard
Dieter Bormann
Walter Duerckheimer
Jean Jolly
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9194564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP931395(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of HRP931395B1 publication Critical patent/HRP931395B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HRP-1917/78A 1977-08-17 1993-11-11 Process for the preparation of crystalline form of sodium salt oxy derivatives of 7-amino-thiazolyl-acetamido-cephalosporin acid HRP931395B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7725142A FR2400519A1 (fr) 1977-08-17 1977-08-17 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
YU1917/78A YU42166B (en) 1977-08-17 1978-08-10 Process for obtaining the crystalline form of the natrium salt of the oxime derivative of 7-amino-thiazolyl acetamido-cephalosporanic acid

Publications (1)

Publication Number Publication Date
HRP931395B1 true HRP931395B1 (en) 1996-04-30

Family

ID=9194564

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP-1917/78A HRP931395B1 (en) 1977-08-17 1993-11-11 Process for the preparation of crystalline form of sodium salt oxy derivatives of 7-amino-thiazolyl-acetamido-cephalosporin acid

Country Status (34)

Country Link
US (1) US4224371A (xx)
EP (1) EP0001024B1 (xx)
JP (1) JPS5441890A (xx)
AT (2) AT366049B (xx)
AU (1) AU520898B2 (xx)
BG (2) BG33887A3 (xx)
CA (1) CA1121343A (xx)
CS (2) CS207646B2 (xx)
DD (1) DD137588A5 (xx)
DE (1) DE2860358D1 (xx)
DK (2) DK152213C (xx)
EG (1) EG13520A (xx)
ES (1) ES472381A1 (xx)
FI (1) FI65433C (xx)
FR (1) FR2400519A1 (xx)
GE (2) GEP19960476B (xx)
GR (1) GR73661B (xx)
HR (1) HRP931395B1 (xx)
HU (1) HU181497B (xx)
IE (1) IE47230B1 (xx)
IL (1) IL55186A (xx)
IT (1) IT1107961B (xx)
MD (2) MD247C2 (xx)
MX (2) MX5448E (xx)
NO (1) NO156168C (xx)
NZ (1) NZ188163A (xx)
OA (1) OA06016A (xx)
PL (1) PL126619B1 (xx)
PT (1) PT68431A (xx)
RO (1) RO79999A (xx)
SI (1) SI7811917A8 (xx)
SU (2) SU799666A3 (xx)
YU (1) YU42166B (xx)
ZA (1) ZA784187B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4937330A (en) * 1985-08-12 1990-06-26 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
RU2021274C1 (ru) 1991-05-17 1994-10-15 Польска Акадэмия Наук Институт Хэмии Органичнэй Способ получения аминотиазолильных производных цефалоспорина
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (de) * 1994-12-23 1997-09-25 Biochemie Gmbh Neues verfahren zur herstellung von cefotaxim
AU690482B2 (en) * 1996-03-18 1998-04-23 Ranbaxy Laboratories Limited Process for producing cephalosporin antibiotics
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
WO2001092254A1 (fr) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Procede permettant de remplacer des solvants contenus dans des cristaux de type clathrates
WO2004063203A1 (en) * 2003-01-10 2004-07-29 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cefotaxime sodium
CN100361995C (zh) * 2004-10-27 2008-01-16 山东瑞阳制药有限公司 注射级无菌头孢噻肟钠的一步法制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970651A (en) * 1974-01-07 1976-07-20 Bristol-Myers Company Crystalline cephalosporin derivative
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
SE440655B (sv) * 1976-01-23 1985-08-12 Roussel Uclaf Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra

Also Published As

Publication number Publication date
JPS5441890A (en) 1979-04-03
US4224371A (en) 1980-09-23
PL126619B1 (en) 1983-08-31
NO156168B (no) 1987-04-27
DD137588A5 (de) 1979-09-12
EP0001024B1 (fr) 1981-01-21
FI65433C (fi) 1984-05-10
GEP19960475B (en) 1996-07-22
IT7850648A0 (it) 1978-08-08
DE2860358D1 (en) 1981-03-12
DK163514C (da) 1992-07-27
SI7811917A8 (en) 1997-12-31
IE781669L (en) 1979-02-17
NO782782L (no) 1979-02-20
DK159786A (da) 1986-04-09
MD225C2 (ro) 1995-12-31
DK152213B (da) 1988-02-08
MD247B1 (ro) 1995-07-31
EP0001024A1 (fr) 1979-03-07
PT68431A (fr) 1978-09-01
NZ188163A (en) 1981-10-19
ZA784187B (en) 1979-09-26
ATA52280A (de) 1981-07-15
CS207647B2 (en) 1981-08-31
FI782494A (fi) 1979-02-18
AU3896578A (en) 1980-02-21
BG33888A3 (en) 1983-05-16
CS207646B2 (en) 1981-08-31
JPS6145626B2 (xx) 1986-10-08
ATA563578A (de) 1981-07-15
MX5448E (es) 1983-08-09
PL209080A1 (pl) 1979-06-04
SU852175A3 (ru) 1981-07-30
YU191778A (en) 1983-02-28
YU42166B (en) 1988-06-30
IT1107961B (it) 1985-12-02
DK152213C (da) 1988-07-11
DK361078A (da) 1979-02-18
NO156168C (no) 1987-08-19
AU520898B2 (en) 1982-03-04
CA1121343A (fr) 1982-04-06
AT366050B (de) 1982-03-10
FR2400519A1 (fr) 1979-03-16
GEP19960476B (en) 1996-07-22
MD225B1 (ro) 1995-06-30
DK163514B (da) 1992-03-09
ES472381A1 (es) 1979-03-16
BG33887A3 (en) 1983-05-16
MD247C2 (ro) 1995-12-31
DK159786D0 (da) 1986-04-09
EG13520A (en) 1982-03-31
MX155976A (es) 1988-06-06
FR2400519B1 (xx) 1980-05-16
HU181497B (en) 1983-07-28
IE47230B1 (en) 1984-01-25
AT366049B (de) 1982-03-10
IL55186A0 (en) 1978-09-29
GR73661B (xx) 1984-03-28
FI65433B (fi) 1984-01-31
IL55186A (en) 1981-07-31
RO79999A (ro) 1982-10-11
OA06016A (fr) 1981-06-30
SU799666A3 (ru) 1981-01-23

Similar Documents

Publication Publication Date Title
GR65303B (en) Process for preparation of phthalazin-4-ylacetic acid derivatives
RO75478B (ro) Procedeu pentru prepararea unor derivati ai acidului alfa-fenoxipropionic
PT72079B (en) Process for the preparation of 7-acylamino-3-vinylcephalosporanic acid derivatives
HRP931395B1 (en) Process for the preparation of crystalline form of sodium salt oxy derivatives of 7-amino-thiazolyl-acetamido-cephalosporin acid
IL52023A0 (en) Process for the preparation of acetic acid derivatives
HU178918B (en) Process for preparing heterocyclic derivatives of unsaturated 7-acylamido-3-cefem-4-carboxylic acid
HU177923B (en) Process for preparing acid addition salts of 7,8-dihydro-14-hydroxy-normorfinone
GB2001640B (en) Process for the preparation of tobias acid
GB2001637B (en) Process for the preparation of tobias acid
SU725555A3 (en) Method of preparing 2-hydrazonopropionic acid derivatives or their salts
PT65932A (en) Process for the preparation of a crystalline modification of a sodium salt
GB2001644B (en) Process for the preparation of tobias acid
IL54206A0 (en) Process for the preparation of , -dialkoxycarboxylic acid derivatives
PT67783A (en) Process for preparing oleanoic acid derivatives
GB1540783A (en) Crystalline potassium salt of beta-nicotinamide-adenine-dinucleotide-phosphoric acid
YU40711B (en) Process for preparing piperazides of pyridine-carboxylic acid
YU135378A (en) Process for the manufacture of new piperazine-dithiocarboxylic acid derivatives
KR780000599B1 (en) Method for crystallization of sodium salt of 5'-inosinic acid
HU184750B (en) Process for the preparation of d-diammonium salt of oxa-beta-lactam-dicarboxylic acid antibiotic
HU174071B (hu) Sposob poluchenija proizvodnykh oksazolino-azetidinil-pentenovoj kisloty
GR65659B (en) Method for preparation of derivatives of cloroulanic acid
YU40822B (en) Process for obtaining salts of indanedione derivatives
YU32578A (en) Process for preparing 3-carboyphenyl-acetic acid derivatives
HU174485B (hu) Sposob poluchenija solejj proizvodnykh ditiokarbaminnojj kisloty
DE2860907D1 (en) Process for the preparation of hydroxylammonium salts

Legal Events

Date Code Title Description
ODRP Renewal fee for the maintenance of a patent

Payment date: 19960228

Year of fee payment: 19

NOST Recognition [ip right]
PBON Lapse due to non-payment of renewal fee

Effective date: 19970228